Announcement on the Establishment of intellim China in Shanghai, China

This is to inform you that intellim Holdings Corporation (President & CEO: Masakuni Ukita/Tokyo Head Office: Taito-ku, Tokyo) established our 4^th overseas office, “intellim China”, in Shanghai, China, on April 1^st, 2019. intellim China will start the business operations on May 6^th, 2019.

1.Background and Aims

intellim Group has been going ahead with the business since 2005 having a vision of “Becoming a Global Clinical Development Partner representing Asia”. Following Korea, Taiwan and Malaysia, we will further promote the development of pharmaceuticals by strengthening the implementation system of clinical studies in China.

2.About the new company, intellim China

Company Name	:	intellim China Corporation
Address	:	Room A, 20th floor, Oriental International Technology Building No. 58 Xiangcheng Road, Pudong New District, Shanghai 200122, P.R. China
President & CEO	:	Masakuni Ukita

3.Business Description

■Drug and Medical Device Development Services in China

1. Establishment of clinical study implementation system to obtain high-quality data and outputs for possibility of filing in Japan
2. Filing and sales support for overseas development items and already-approved items in China
3. Provision of essential education for clinical study